Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2012Cancer ResearchOpen Access

Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAshley A. ManzoorDuke UniversityLLLars H. LindnerLMU KlinikumCLChelsea D. LandonUniversity of North Carolina at Charlotte

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Manzoor et al. (2012) studied this question.

synapsesocial.com/papers/6a8bbad8f8241cb45bfb67dehttps://doi.org/10.1158/0008-5472.can-12-1683
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Mathematical Model for Comparison of Bolus Injection, Continuous Infusion, and Liposomal Delivery of Doxorubicin to Tumor Cells2000 · 148 citations
  2. 2Liposomes and Local Hyperthermia: Selective Delivery of Methotrexate to Heated Tumors1979 · 363 citations
  3. 3Phase I Trial of Doxorubicin-Containing Low Temperature Sensitive Liposomes in Spontaneous Canine Tumors2006 · 155 citations
  4. 4The Distribution of the Anticancer Drug Doxorubicin in Relation to Blood Vessels in Solid Tumors2005 · 507 citations